Prilocaine or Bupivacaine for Spinal Anesthesiain Pregnant
NCT ID: NCT03433976
Last Updated: 2018-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
50 participants
INTERVENTIONAL
2018-05-07
2020-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The number of subjects required is 50 patients, 25 per group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hyperbaric Bupivacaine
spinal anesthesia for planned cesarean sections control group
spinal anesthesia
spinal anesthesia for planned cesarean sections
Hyperbaric Prilocaïne
spinal anesthesia for planned cesarean sections
spinal anesthesia
spinal anesthesia for planned cesarean sections
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
spinal anesthesia
spinal anesthesia for planned cesarean sections
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled caesarean section
* Non-multiple pregnancy
* Age of patient: 18 years and over
* Height of patient: between 155 and 175 cm
* Affiliated patients or beneficiaries of a Social Security System
* Signature of the patient's consent
Exclusion Criteria
* Pathological pregnancy
* Multiple pregnancy
* Emergency caesarean
* Patients who cannot give informed consent (not French speaking)
* Refusal of the patient
* Contraindications to spinal anesthesia
* Contraindications to Prilocaine
* Contraindications to Bupivacaine
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Saint Roch
OTHER
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
christophe DADURE
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uhmontpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Christophe DADURE, MD, phD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Chapron K, Sleth JC, Capdevila X, Bringuier S, Dadure C. Hyperbaric prilocaine vs. hyperbaric bupivacaine for spinal anaesthesia in women undergoing elective caesarean section: a comparative randomised double-blind study. Anaesthesia. 2021 Jun;76(6):777-784. doi: 10.1111/anae.15342. Epub 2021 Jan 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UF9859
Identifier Type: -
Identifier Source: org_study_id